Daiichi Sankyo to Terminates Vaccine Business Alliance with Sanofi in Japan

Daiichi Sankyo and Sanofi terminated on March 31 their marketing agreement for the tetravalent vaccine Squarekids subcutaneous injection syringe and a joint development agreement on the pentavalent combination vaccine VN-0105 in Japan. Squarekids combines Daiichi Sankyo’s DPT (diphtheria, pertussis, and...read more